Telmisartan did not prevent recurrent stroke or major cardiovascular events Yusuf S - Groups did not differ for recurrent stroke, major cardiovascular events, or new-onset diabetes. In patients with ischaemic stroke, telmisartan did not prevent recurrent stroke, major cardiovascular events, or new-onset diabetes more than placebo. [more...]
